| Knowledge4COVID-19

Property	Value
is ?:annotates of	<https://research.tib.eu/covid-19/entity/34182120_HAS_TOPIC_C0086418> <https://research.tib.eu/covid-19/entity/34182120_HAS_TOPIC_C1113679> <https://research.tib.eu/covid-19/entity/34182120_HAS_TOPIC_C1615608> <https://research.tib.eu/covid-19/entity/34182120_HAS_TOPIC_C5203670> <https://research.tib.eu/covid-19/entity/34182120_HAS_TOPIC_C5203676> <https://research.tib.eu/covid-19/entity/34182120_HAS_TOPIC_C5392141>
?:authorAffiliation	[\'Cytokinetics, South San Francisco, CA 94080, United States of America. Electronic address: mpugsley@cytokinetics.com.\', \'Abbvie, North Chicago, IL 60064, United States of America.\', \'Ncardia, Leiden 2333, BD, the Netherlands.\', \'Charles River Laboratories, Laval, QC H7V 4B3, Canada.\', \'Cardiovascular Division, King\'s College London, Rayne Institute, St Thomas\' Hospital, London SE17EH, UK.\']
?:citedBy	-1
?:creator	<https://research.tib.eu/covid-19/entity/Authier_Simon> <https://research.tib.eu/covid-19/entity/Curtis_Michael_J> <https://research.tib.eu/covid-19/entity/Koshman_Yevgeniya> <https://research.tib.eu/covid-19/entity/Pugsley_Michael_K> <https://research.tib.eu/covid-19/entity/de_Korte_Tessa>
?:doi	<https://research.tib.eu/covid-19/entity/S1056-8719%2821%2900141-610.1016/j.vascn.2021.107089>
?:doi	S1056-8719(21)00141-610.1016/j.vascn.2021.107089
?:hasPublicationType	<https://research.tib.eu/covid-19/entity/Congress> <https://research.tib.eu/covid-19/entity/Editorial>
?:journal	Journal of pharmacological and toxicological methods
is ?:pmid of	<https://research.tib.eu/covid-19/entity/34182120>
?:pmid	<https://research.tib.eu/covid-19/entity/34182120>
?:pmid	34182120
?:publication_isRelatedTo_Disease	<https://research.tib.eu/covid-19/entity/Covid-19>
?:rankingScore_SJR	0.75
?:rankingScore_hIndex	62
?:title	Safety pharmacology during the COVID pandemic.
?:type	<https://research.tib.eu/covid-19/vocab/Publication> <https://research.tib.eu/covid-19/vocab/Publication_Author>

Metadata

Anon_0

<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>

<http://purl.org/net/provenance/ns#DataItem>

<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>

<http://www.w3.org/2004/03/trix/rdfg-1/Graph>

<http://xmlns.com/foaf/0.1/primaryTopic>

<https://research.tib.eu/covid-19/entity/34182120>

<http://xmlns.com/foaf/0.1/topic>

Anon_0

<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes>

<https://research.tib.eu/covid-19/data/entity/34182120>

<http://purl.org/net/provenance/ns#createdBy>

Anon_1 (more)

expand all